-
Lose the big bet! Gilead's anti-cancer drug trials have shown poor results, and its stock price has plummeted by over 10%
US pharmaceutical giant Gilead announced on Monday that its anti-cancer drug Trodelvy failed to significantly improve survival rates in a trial of advanced lung cancer patients, causing its stock pri ... -
Li Xiang, CEO of Ideal Automobile: Reviewing the areas where we did not do well in 2023
According to AI News, Li Xiang, CEO of Ideal Automobile, posted on his official WeChat account that he did not do well in the 2023 review. 1. Sales are not good. Sales of 376000 vehicles, of which 40 ...